Khattab Mohamed H, Newman Neil B, Wharton David M, Sherry Alexander D, Luo Guozhen, Manzoor Nauman F, Rivas Alejandro, Davis L Taylor, Chambless Lola B, Attia Albert, Cmelak Anthony J
Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Vanderbilt University School of Medicine, Nashville, Tennessee, United States.
J Neurol Surg B Skull Base. 2020 Jun;81(3):308-316. doi: 10.1055/s-0039-1692642. Epub 2019 Jun 12.
Management of vestibular schwannoma (VS) includes stereotactic radiosurgery (SRS) in single or fractionated treatments. There is a paucity of literature on the three-dimensional (3D) volumetric kinetics and radiological changes following SRS and no consensus on appropriate post-SRS surveillance imaging timeline. This is a retrospective cohort study with institutional review board approval. A total of 55 patients met study criteria. We collected volumetric kinetic data in VS treated with SRS over time using a target volume contouring software. We also tracked radiographic phenomena such as pseudoprogression and necrosis. A secondary objective was to describe our overall treatment success rate and any failures. For all treatments groups, pseudoprogression most typically occurred within 12 months post-SRS, after which tumor volumes on average normalized and then decreased from pretreatment size at the last follow-up. Only two patients required salvage therapy post-SRS and were considered SRS treatment failures. Both patients were in the five-fraction cohort but with a lower biologically equivalent dose. Our study is first to collect 3D volumetric kinetics of VS following single and fractionated SRS in contrast to extrapolations from single and two-dimensional measurements. Our longitudinal data also show initial increases in volume in the first 12 months post-SRS followed by later declines, setting up interesting questions regarding the utility of early posttreatment surveillance imaging in the asymptomatic patient. Finally, we show low rates of treatment failure (3.6%) and show in our cohort that SRS dose de-escalation posed a risk of treatment failure.
前庭神经鞘瘤(VS)的治疗方法包括单次或分次立体定向放射外科治疗(SRS)。关于SRS后的三维(3D)体积动力学和放射学变化的文献较少,且对于SRS后合适的监测成像时间线尚无共识。这是一项经机构审查委员会批准的回顾性队列研究。共有55例患者符合研究标准。我们使用靶区体积勾画软件,随时间收集接受SRS治疗的VS的体积动力学数据。我们还追踪了诸如假性进展和坏死等影像学现象。第二个目标是描述我们的总体治疗成功率和任何治疗失败情况。对于所有治疗组,假性进展最常发生在SRS后的12个月内,之后肿瘤体积平均恢复正常,然后在最后一次随访时较治疗前大小减小。只有2例患者在SRS后需要挽救治疗,被视为SRS治疗失败。这两名患者均在五分次队列中,但生物等效剂量较低。我们的研究首次收集了单次和分次SRS后VS的3D体积动力学数据,与从单次和二维测量推断的数据形成对比。我们的纵向数据还显示,SRS后最初12个月内体积增加,随后下降,这引发了关于无症状患者治疗后早期监测成像效用的有趣问题。最后,我们显示治疗失败率较低(3.6%),并且在我们的队列中表明SRS剂量降低存在治疗失败的风险。